Phosphoprotein phosphatase 2A: a novel druggable target for Alzheimer’s disease
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Phosphoprotein phosphatase 2A: a novel druggable target for Alzheimer’s disease
Authors
Keywords
-
Journal
Future Medicinal Chemistry
Volume 3, Issue 7, Pages 821-833
Publisher
Future Science, LTD
Online
2011-06-06
DOI
10.4155/fmc.11.47
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cdc25B Phosphatase Inhibitors in Cancer Therapy: Latest Developments, Trends and Medicinal Chemistry Perspective
- (2012) Antonio Lavecchia et al. Anti-Cancer Agents in Medicinal Chemistry
- Enhanced Phosphatase Activity Attenuates -Synucleinopathy in a Mouse Model
- (2011) K.-W. Lee et al. JOURNAL OF NEUROSCIENCE
- Open-label, phase I dose-escalation study of sodium selenate, a novel activator of PP2A, in patients with castration-resistant prostate cancer
- (2010) N M Corcoran et al. BRITISH JOURNAL OF CANCER
- Vitamin E Forms in Alzheimer's Disease: A Review of Controversial and Clinical Experiences
- (2010) Owoedimo B. Usoro et al. CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION
- The carboxy-terminal fragment of inhibitor-2 of protein phosphatase-2A induces Alzheimer disease pathology and cognitive impairment
- (2010) Xiaochuan Wang et al. FASEB JOURNAL
- Sphingosine Interaction with Acidic Leucine-rich Nuclear Phosphoprotein-32A (ANP32A) Regulates PP2A Activity and Cyclooxygenase (COX)-2 Expression in Human Endothelial Cells
- (2010) Cheryl Habrukowich et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Phosphorylation of Tau at Thr212, Thr231, and Ser262Combined Causes Neurodegeneration
- (2010) Alejandra D. Alonso et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Discovery of Brain-Penetrant, Orally Bioavailable Aminothienopyridazine Inhibitors of Tau Aggregation
- (2010) Carlo Ballatore et al. JOURNAL OF MEDICINAL CHEMISTRY
- Synthesis, Inhibitory Activity of Cholinesterases, and Neuroprotective Profile of Novel 1,8-Naphthyridine Derivatives
- (2010) Cristóbal de los Ríos et al. JOURNAL OF MEDICINAL CHEMISTRY
- Inhibition of c-Jun kinase provides neuroprotection in a model of Alzheimer's disease
- (2010) Steven P. Braithwaite et al. NEUROBIOLOGY OF DISEASE
- Sodium selenate mitigates tau pathology, neurodegeneration, and functional deficits in Alzheimer's disease models
- (2010) J. van Eersel et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Development of Tau Aggregation Inhibitors for Alzheimer's Disease
- (2009) Bruno Bulic et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Nutritional status of selenium in Alzheimer's disease patients
- (2009) Bárbara Rita Cardoso et al. BRITISH JOURNAL OF NUTRITION
- Taurolidine and oxidative stress: a rationale for local treatment of mesothelioma
- (2009) N. Aceto et al. EUROPEAN RESPIRATORY JOURNAL
- Progesterone decreases tyrosine hydroxylase phosphorylation state and increases protein phosphatase 2A activity in the stalk-median eminence on proestrous afternoon
- (2009) Bin Liu et al. JOURNAL OF ENDOCRINOLOGY
- Structure−Activity Relationship of Cyanine Tau Aggregation Inhibitors
- (2009) Edward Chang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Activation of p38 Mitogen-Activated Protein Kinase Is Required for Death Receptor-Independent Caspase-8 Activation and Cell Death in Response to Sphingosine
- (2009) C.-H. Yoon et al. MOLECULAR CANCER RESEARCH
- JNK regulates APP cleavage and degradation in a model of Alzheimer's disease
- (2009) Alessio Colombo et al. NEUROBIOLOGY OF DISEASE
- Dithiolethione compounds inhibit Akt signaling in human breast and lung cancer cells by increasing PP2A activity
- (2009) C H Switzer et al. ONCOGENE
- Protein phosphatase 2A (PP2A), a drugable tumor suppressor in Ph1(+) leukemias
- (2008) Danilo Perrotti et al. CANCER AND METASTASIS REVIEWS
- Structural Mechanism of Demethylation and Inactivation of Protein Phosphatase 2A
- (2008) Yongna Xing et al. CELL
- Direct interaction between the inhibitor 2 and ceramide via sphingolipid-protein binding is involved in the regulation of protein phosphatase 2A activity and signaling
- (2008) Archana Mukhopadhyay et al. FASEB JOURNAL
- Tau hyperphosphorylation correlates with reduced methylation of protein phosphatase 2A
- (2008) Xin-Wen Zhou et al. NEUROBIOLOGY OF DISEASE
- Linking Aβ and Tau in Late-Onset Alzheimer's Disease: A Dual Pathway Hypothesis
- (2008) Scott A. Small et al. NEURON
- Tau-based treatment strategies in neurodegenerative diseases
- (2008) Anja Schneider et al. Neurotherapeutics
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started